(Q48226763)

9 February 2018

title

Impaired amyloid β-degrading enzymes in brain of streptozotocin-induced diabetic rats (English)

1 reference

9 February 2018

author name string

Y Liu

1

1 reference

9 February 2018

L Liu

2

1 reference

9 February 2018

S Lu

3

1 reference

9 February 2018

D Wang

4

1 reference

9 February 2018

X Liu

5

1 reference

9 February 2018

L Xie

6

1 reference

9 February 2018

G Wang

7

1 reference

9 February 2018

publication date

22 April 2010

1 reference

9 February 2018

Journal of Endocrinological Investigation

published in

1 reference

9 February 2018

volume

34

1 reference

9 February 2018

issue

1

1 reference

9 February 2018

page(s)

26-31

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1007/bf03346691

exact match

0 references

cites work

Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Abeta-degrading enzymes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Amyloid-degrading enzymes as therapeutic targets in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Inhibition of neprilysin by thiorphan (i.c.v.) causes an accumulation of amyloid beta and impairment of learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

HIV-1 Tat inhibits neprilysin and elevates amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Metabolic regulation of brain Abeta by neprilysin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Alzheimer-like changes in rat models of spontaneous diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Increased amyloid beta-peptide (1-40) level in brain of streptozotocin-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Peptidase activities in human semen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Concentrations of insulin and insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Identification of hippocampus-related candidate genes for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Molecular pharmacology of endothelin converting enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Neprylisin decreases uniformly in Alzheimer's disease and in normal aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Decreased neprilysin immunoreactivity in Alzheimer disease, but not in pathological aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Insulin-degrading enzyme as a downstream target of insulin receptor signaling cascade: implications for Alzheimer's disease intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Downregulation of LRP1 [correction of LPR1] at the blood-brain barrier in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Upregulation of RAGE at the blood-brain barrier in streptozotocin-induced diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03346691

Clearance of Alzheimer's Abeta peptide: the many roads to perdition.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20414044

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF03346691

1 reference

9 February 2018

1 reference

9 February 2018